{"id":"NCT00951275","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis","officialTitle":"A Single Arm, Open-label Study of Early Improvement of Anemia and Fatigue During Treatment With Tocilizumab (TCZ) in Combination With DMARDs, in Adult Patients With Moderate to Severe Active Rheumatoid Arthritis.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10-31","primaryCompletion":"2011-07-22","completion":"2011-07-22","firstPosted":"2009-08-04","resultsPosted":"2014-08-12","lastUpdate":"2017-08-03"},"enrollment":105,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"tocilizumab [RoActemra/Actemra]","otherNames":[]},{"type":"DRUG","name":"Standard DMARDs (Disease Modifying Anti Rheumatic Drugs)","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"This single arm study will assess the effect of tocilizumab + DMARDs (Disease Modifying Anti-Rheumatic Drugs)on improvement of anemia and fatigue in patients with moderate to severe active rheumatoid arthritis. Eligible patients who have had an inadequate response to DMARDs will receive tocilizumab 8mg/kg iv every 4 weeks in combination with standard DMARDs, for 6 months. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals.","primaryOutcome":{"measure":"Improvement of Anemia at Week 4 Assessed as Change From Baseline in Hemoglobin","timeFrame":"Week 4","effectByArm":[{"arm":"Tocilizumab 8 mg/kg","deltaMin":0.4,"sd":0.78}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":27,"countries":["Italy"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":105},"commonTop":["Hypercholesterolaemia","Nausea","Transaminases increased","Bronchitis","Iron deficiency anaemia"]}}